# Baxter Pharmaceutical Solutions, LLC, Bloomington, IN – FDA Inspections

Source: https://www.keypedia.com/companies/baxter-pharmaceutical-solutions-llc/dd8344ef-ad46-49b8-8b39-fb1d8cb518d8

> Inspection records and compliance data for Baxter Pharmaceutical Solutions, LLC in Bloomington, Indiana. 20 FDA inspections on record, 6 Form 483s, last inspected December 11, 2025.

---

## Details

- Name: Baxter Pharmaceutical Solutions, LLC
- FEI Number: 1000115571
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK
- Address Line 1: 927 S Curry Pike
- City: Bloomington
- State: Indiana
- Zip Code: 47403
- Country Name: United States
- Address: 927 S Curry Pike, Bloomington, Indiana 47403, United States
- Country: United States

## Inspection summary

- FDA inspections: 20 (October 30, 2009 to December 11, 2025)
- Classifications: NAI 5, VAI 11
- Form 483s: 6
- Warning letters: 0
- Most cited issues: Extent of discrepancy, failure  investigations (2); Procedures not  in writing, fully followed (2); Certificates of Testing (Containers, Closures) (1)

## FDA inspections

- [December 11, 2025](https://www.keypedia.com/records/fda_inspections/baxter-pharmaceutical-solutions-llc/e3888c4a-f3ae-412d-ba8b-7ba36c4e3491) — Biologics, Blood and Blood Products, Form 483 issued
- [September 24, 2024](https://www.keypedia.com/records/fda_inspections/baxter-pharmaceutical-solutions-llc/5e099ee8-4e07-4b90-85f5-484e0918b190) — Human Drugs, Form 483 issued
- [July 26, 2024](https://www.keypedia.com/records/fda_inspections/baxter-pharmaceutical-solutions-llc/b3d0c5d3-833d-424f-9987-928d1ad62f9f) — Biologics, Form 483 issued
- [February 20, 2024](https://www.keypedia.com/records/fda_inspections/baxter-pharmaceutical-solutions-llc/1096b217-7488-424a-96e2-821302093f1b) — Human Drugs, Form 483 issued
- February 17, 2023 — No Action Indicated (NAI), Human Drugs, Drug Quality Assurance
- November 10, 2021 — Voluntary Action Indicated (VAI), Biologics, Vaccines and Allergenic Products
- [May 23, 2018](https://www.keypedia.com/records/fda_inspections/baxter-pharmaceutical-solutions-llc/a8a9268a-9813-4e4f-b671-eae53fa1f68d) — Voluntary Action Indicated (VAI), Biologics, Blood and Blood Products, Form 483 issued
- [July 17, 2017](https://www.keypedia.com/records/fda_inspections/baxter-pharmaceutical-solutions-llc/4892691b-652a-49f3-8669-5459d493badb) — Voluntary Action Indicated (VAI), Human Drugs, Drug Quality Assurance, Form 483 issued
- May 12, 2016 — Voluntary Action Indicated (VAI), Biologics, Vaccines and Allergenic Products
- October 24, 2014 — Voluntary Action Indicated (VAI), Human Drugs, Drug Quality Assurance
- May 2, 2014 — No Action Indicated (NAI), Human Drugs, Drug Quality Assurance
- [May 10, 2013](https://www.keypedia.com/records/fda_inspections/baxter-pharmaceutical-solutions-llc/f561ecc7-6269-4399-82f0-b1a2264a49dd) — Voluntary Action Indicated (VAI), Human Drugs, Drug Quality Assurance
- [March 12, 2013](https://www.keypedia.com/records/fda_inspections/baxter-pharmaceutical-solutions-llc/95ca7fb0-7547-43ed-a464-d8087b733cd9) — Voluntary Action Indicated (VAI), Human Drugs, Drug Quality Assurance
- September 27, 2012 — Voluntary Action Indicated (VAI), Human Drugs, Drug Quality Assurance
- August 16, 2011 — No Action Indicated (NAI), Human Drugs, Drug Quality Assurance
- June 17, 2011 — No Action Indicated (NAI), Biologics, Vaccines and Allergenic Products
- [March 25, 2011](https://www.keypedia.com/records/fda_inspections/baxter-pharmaceutical-solutions-llc/6fc3a110-4032-444f-bcdb-9bd104ba9446) — Voluntary Action Indicated (VAI), Human Drugs, Drug Quality Assurance
- [September 23, 2010](https://www.keypedia.com/records/fda_inspections/baxter-pharmaceutical-solutions-llc/f4da5ce7-e1e0-4a55-a3ab-fbc167114943) — Voluntary Action Indicated (VAI), Human Drugs, Drug Quality Assurance
- March 24, 2010 — Voluntary Action Indicated (VAI), Biologics, Vaccines and Allergenic Products
- October 30, 2009 — No Action Indicated (NAI), Animal Drugs & Feeds, Human Drugs, Drug Quality Assurance

## Form 483s (4)

- [483 - Baxter Pharmaceutical Solutions, LLC - 2024-02-20](https://www.keypedia.com/records/483/baxter-pharmaceutical-solutions-llc/eb37852c-d304-4aa1-b686-b66af3adb296) — February 20, 2024
- [483 - Baxter Pharmaceutical Solutions, LLC - 2021-11-10](https://www.keypedia.com/records/483/baxter-pharmaceutical-solutions-llc/e58a0478-5a31-4b0c-bf8f-43a2a2cd7673) — November 10, 2021
- [483 - Baxter Pharmaceutical Solutions, LLC - date not listed](https://www.keypedia.com/records/483/baxter-pharmaceutical-solutions-llc/18f3a643-f7a3-4880-971e-adfe35384dca)
- [483 - Baxter Pharmaceutical Solutions, LLC - date not listed](https://www.keypedia.com/records/483/baxter-pharmaceutical-solutions-llc/c2258424-7ec3-4182-846d-ce66b310826f)

## Other regulators

- [UK MHRA](https://www.keypedia.com/records/uk_mhra_gmp/baxter-pharmaceutical-solutions-llc/f7827ff5-cc94-4e1b-824e-eda1f1e8be94) — 1 record, latest April 3, 2017

## Related Documents

- [483 - Baxter Pharmaceutical Solutions, LLC - Unknown Date](https://www.keypedia.com/records/483/baxter-pharmaceutical-solutions-llc/18f3a643-f7a3-4880-971e-adfe35384dca) — source: FDA, date: Invalid Date
- [483 - Baxter Pharmaceutical Solutions, LLC - Unknown Date](https://www.keypedia.com/records/483/baxter-pharmaceutical-solutions-llc/c2258424-7ec3-4182-846d-ce66b310826f) — source: FDA, date: Invalid Date
- FDA Inspection 1290838 - Baxter Pharmaceutical Solutions, LLC - 2025-12-11 — source: FDA, date: December 11, 2025
- [FDA Inspection 1290838 - Baxter Pharmaceutical Solutions, LLC - 2025-12-11](https://www.keypedia.com/records/fda_inspections/baxter-pharmaceutical-solutions-llc/e3888c4a-f3ae-412d-ba8b-7ba36c4e3491) — source: FDA, date: December 11, 2025
- [FDA Inspection 1242468 - Baxter Pharmaceutical Solutions, LLC - 2024-09-24](https://www.keypedia.com/records/fda_inspections/baxter-pharmaceutical-solutions-llc/5e099ee8-4e07-4b90-85f5-484e0918b190) — source: FDA, date: September 24, 2024
- FDA Inspection 1242468 - Baxter Pharmaceutical Solutions, LLC - 2024-09-24 — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 24, 2024
- [FDA Inspection 1243512 - Baxter Pharmaceutical Solutions, LLC - 2024-07-26](https://www.keypedia.com/records/fda_inspections/baxter-pharmaceutical-solutions-llc/b3d0c5d3-833d-424f-9987-928d1ad62f9f) — source: FDA, date: July 26, 2024
- [483 - Baxter Pharmaceutical Solutions, LLC - 2024-02-20](https://www.keypedia.com/records/483/baxter-pharmaceutical-solutions-llc/eb37852c-d304-4aa1-b686-b66af3adb296) — source: FDA, date: February 20, 2024
- [FDA Inspection 1230675 - Baxter Pharmaceutical Solutions, LLC - 2024-02-20](https://www.keypedia.com/records/fda_inspections/baxter-pharmaceutical-solutions-llc/1096b217-7488-424a-96e2-821302093f1b) — source: FDA, date: February 20, 2024
- FDA Inspection 1200813 - Baxter Pharmaceutical Solutions, LLC - 2023-02-17 — classification: No Action Indicated (NAI), source: FDA, date: February 17, 2023
- [483 - Baxter Pharmaceutical Solutions, LLC - 2021-11-10](https://www.keypedia.com/records/483/baxter-pharmaceutical-solutions-llc/e58a0478-5a31-4b0c-bf8f-43a2a2cd7673) — source: FDA, date: November 10, 2021
- FDA Inspection 1157719 - Baxter Pharmaceutical Solutions, LLC - 2021-11-10 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 10, 2021
- [FDA Inspection 1060004 - Baxter Pharmaceutical Solutions, LLC - 2018-05-23](https://www.keypedia.com/records/fda_inspections/baxter-pharmaceutical-solutions-llc/a8a9268a-9813-4e4f-b671-eae53fa1f68d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 23, 2018
- FDA Inspection 1060004 - Baxter Pharmaceutical Solutions, LLC - 2018-05-23 — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 23, 2018

## Related Companies

- [Sanofi Winthrop Industrie](https://www.keypedia.com/companies/sanofi-winthrop-industrie/c811b5aa-08fe-4a09-ae00-f302ada6f489)
- [ROVI Pharma Industrial Services S.A.](https://www.keypedia.com/companies/rovi-pharma-industrial-services-sa/7358680b-374e-46ed-8afb-ff7040bcf1e4)
- [ENDO USA, Inc.](https://www.keypedia.com/companies/endo-usa-inc/f2df2e47-8303-4a2c-9881-5e2ecef64f22)
- [OKC Allergy Supplies, Inc.](https://www.keypedia.com/companies/okc-allergy-supplies-inc/2de8c1af-5a53-4bcb-835d-5b8984c66015)
- [Terumo BCT Ltd](https://www.keypedia.com/companies/terumo-bct-ltd/182a5d92-4c5c-4393-95cd-45250ca7eb25)
- [Grand River Aseptic Manufacturing Inc.](https://www.keypedia.com/companies/grand-river-aseptic-manufacturing-inc/f538a5fa-320e-4240-954d-762b7d02795a)
- [Terumo Corporation Fujinomiya Factory](https://www.keypedia.com/companies/terumo-corporation-fujinomiya-factory/82a74871-bc83-43dc-b1cc-7ae24148d80f)
- [B. Braun Medical Inc](https://www.keypedia.com/companies/b-braun-medical-inc/7d193a37-e8a0-4f0f-aeea-f64ccd959191)
- [Fresenius Medical Care, North America](https://www.keypedia.com/companies/fresenius-medical-care-north-america/90cbe724-7310-49e8-983b-b062488d9710)
- [Fenwal International, Inc.](https://www.keypedia.com/companies/fenwal-international-inc/f7736da8-9a5b-421a-8f73-803b3504d456)

## Related Officers

- [investigator](https://www.keypedia.com/people/susan-m-jackson/2a4e01d1-8761-4d40-b493-69a4163473bb)
- [National Expert, Pharmaceutical](https://www.keypedia.com/people/simone-e-pitts/e405f1fc-4aff-4202-b216-ddbdc342d108)
- [Brenton Collins, CSO](https://www.keypedia.com/people/brenton-collins-cso/0dcb7303-2d8b-469c-a595-80b6c2a76099)
- [Scott T. Ballard](https://www.keypedia.com/people/scott-t-ballard/09b2ae9a-3b30-45bd-bac1-437365e938da)
- [Yiwei Li](https://www.keypedia.com/people/yiwei-li/e5ea2c24-8e1e-43be-be23-e276b8848cff)
- [Laurimer Kuilan-Torres](https://www.keypedia.com/people/laurimer-kuilan-torres/a7f49e33-9d35-4dfe-8bcc-d369d3834ef4)
